Clinical trial

Multicenter Study to Evaluate the Effect of BTI320 on Glycemic Control in Type 2 Diabetes

NCT03655535

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-09-19

PhasePHASE2

Study timeline

Study start (actual)2018-09-19Date precision: day

Registry last updated2020-09-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type2 Diabetes Mellitusunresolved

Interventions

BTI320DRUG

PlaceboOTHER

Sponsors & collaborators

Boston Therapeuticslead sponsor

Sugardown Company Limitedcollaborator

Mapped research locations

AlbuquerqueNew Mexico, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03655535 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.